(Q46960044)

26 December 2017

title

Etoposide attenuates zymosan-induced shock in mice (English)

1 reference

26 December 2017

1 reference

3

1 reference

26 December 2017

author name string

M Remichkova

series ordinal

1

1 reference

26 December 2017

M Yordanov

series ordinal

2

1 reference

26 December 2017

publication date

9 October 2007

1 reference

26 December 2017

published in

Inflammation

1 reference

26 December 2017

volume

31

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

57-64

1 reference

26 December 2017

The biology of cachectin/TNF--a primary mediator of the host response

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10753-007-9049-8

Sepsis and cytokines: current status

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10753-007-9049-8

Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10753-007-9049-8

Impact of topoisomerase II inhibition on cytokine and chemokine production

21 January 2018

1 reference

12 December 2020

Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase

1 reference

12 December 2020

Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice.

1 reference

12 December 2020

Etoposide. Current and future status

1 reference

12 December 2020

A question of balance

1 reference

12 December 2020

Murine TLR2 expression analysis and systemic antagonism by usage of specific monoclonal antibodies

1 reference

12 December 2020

Macrophage recognition of zymosan particles

1 reference

12 December 2020

Sepsis in the critically ill patient

1 reference

12 December 2020

Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis

1 reference

12 December 2020

Multiple-organ failure and sepsis without bacteria. An experimental model

1 reference

12 December 2020

Influence of cytostatic agents on the pulmonary defence of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone

1 reference

12 December 2020

The role of tumor necrosis factor in the development of multiple organ failure in a murine model

1 reference

12 December 2020

Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome

1 reference

12 December 2020

Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model

1 reference

12 December 2020

Systemic inflammatory response syndrome

1 reference

12 December 2020

Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock

1 reference

12 December 2020

Etoposide: four decades of development of a topoisomerase II inhibitor

1 reference

12 December 2020

Elimination of various subpopulations of macrophages and the development of multiple-organ dysfunction syndrome in mice

1 reference

12 December 2020

Toxicity of the topoisomerase II inhibitors

1 reference

12 December 2020

Role of the neutrophil in septic shock and the adult respiratory distress syndrome

1 reference

12 December 2020

Current status of etoposide in the management of small cell lung cancer

1 reference

12 December 2020

The molecular pathogenesis of endotoxic shock and organ failure

1 reference

12 December 2020

Animal models of sepsis and shock: a review and lessons learned.

1 reference

12 December 2020

Mechanisms and management of myocardial dysfunction in septic shock

1 reference

12 December 2020

10.1007/S10753-007-9049-8

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017